We are live on ! Find out more
ICM

Invenomic Capital Management Portfolio holdings

AUM $2.18B
1-Year Est. Return 0.03%
This Fund
S&P 500
This Quarter Est. Return
+14.24%
1 Year Est. Return
+0.03%
3 Year Est. Return
-6.37%
5 Year Est. Return
-25.27%
10 Year Est. Return
AUM
$2.19B
AUM Growth
-$189M
Cap. Flow
-$471M
Cap. Flow %
-21.5%
Top 10 Hldgs %
25.76%
Holding
204
New
59
Increased
25
Reduced
88
Closed
32

Top Buys

Rank Stock Value
1
SEDG icon
SolarEdge
SEDG
+$41.5M
2
ILMN icon
Illumina
ILMN
+$40.9M
3
QDEL icon
QuidelOrtho
QDEL
+$34.1M
4
CIVI
Civitas Resources
CIVI
+$18.5M
5
FMC icon
FMC
FMC
+$17.3M

Sector Composition

Rank Sector Weight
1 Technology 18.91%
2 Consumer Discretionary 12.94%
3 Healthcare 12.41%
4 Communication Services 8.9%
5 Industrials 7.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KFY icon
126
Korn Ferry
KFY
$4.25B
$3.21M 0.15%
54,134
+10,124
+23% +$517K
ADT icon
127
ADT
ADT
$5.49B
$3.14M 0.14%
+460,609
New +$2.87M
REZI icon
128
Resideo Technologies
REZI
$3.67B
$3.06M 0.14%
+162,856
New +$2.67M
SNDR icon
129
Schneider National
SNDR
$6.18B
$3.05M 0.14%
+119,738
New +$2.95M
DSP icon
130
Viant Technology
DSP
$282M
$3.03M 0.14%
439,371
-92,496
-17% -$556K
LUV icon
131
Southwest Airlines
LUV
$22B
$2.84M 0.13%
98,181
-179,566
-65% -$4.67M
RSKD icon
132
Riskified
RSKD
$712M
$2.75M 0.13%
+588,250
New +$2.41M
EVBG
133
DELISTED
Everbridge, Inc. Common Stock
EVBG
$2.72M 0.12%
+112,071
New +$2.42M
HLMN icon
134
Hillman Solutions
HLMN
$1.77B
$2.72M 0.12%
+295,008
New +$2.25M
AVNS
135
DELISTED
Avanos Medical
AVNS
$2.68M 0.12%
119,605
-36,331
-23% -$750K
WWW icon
136
Wolverine World Wide
WWW
$1.55B
$2.59M 0.12%
291,102
-279,528
-49% -$2.38M
SEAT icon
137
Vivid Seats
SEAT
$82.6M
$2.5M 0.11%
19,766
-14,571
-42% -$2M
CPAY icon
138
Corpay
CPAY
$26.2B
$2.36M 0.11%
8,364
-161,834
-95% -$40.2M
NDLS icon
139
Noodles & Co
NDLS
$96M
$2.3M 0.11%
91,377
-14,054
-13% -$307K
DOMO icon
140
Domo
DOMO
$189M
$2.3M 0.1%
223,106
-194,544
-47% -$1.8M
MEI icon
141
Methode Electronics
MEI
$581M
$2.23M 0.1%
+98,154
New +$2.3M
SSL icon
142
Sasol
SSL
$7.38B
$2.23M 0.1%
224,297
-210,838
-48% -$2.48M
NGVT icon
143
Ingevity
NGVT
$2.65B
$2.2M 0.1%
+46,584
New +$1.93M
HURC icon
144
Hurco Companies Inc
HURC
$141M
$2.05M 0.09%
95,220
-4,220
-4% -$87.8K
SMP icon
145
Standard Motor Products
SMP
$885M
$2.04M 0.09%
51,304
-27,676
-35% -$987K
TIXT
146
DELISTED
TELUS International
TIXT
$1.94M 0.09%
226,097
-150,186
-40% -$1.09M
EAF icon
147
GrafTech
EAF
$205M
$1.68M 0.08%
+76,882
New +$2.17M
PETS icon
148
PetMed Express
PETS
$42.1M
$1.63M 0.07%
+215,800
New +$1.77M
CMTL icon
149
Comtech Telecommunications
CMTL
$51.5M
$1.59M 0.07%
+188,887
New +$1.97M
UNFI icon
150
United Natural Foods
UNFI
$2.8B
$1.5M 0.07%
+92,235
New +$1.4M

Similar funds

Invenomic Capital Management's Q4 2023 Portfolio in Review

As of Q4 2023, Invenomic Capital Management held 204 positions worth $2.19B, down 7.9% from $2.38B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Invenomic Capital Management withdrew a net $471M in Q4 2023, closing 32 positions and reducing 88 holdings. Its most notable exit was State Street SPDR S&P 500 ETF Trust, an estimated $245M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 23% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Invenomic Capital Management opened a new position in SolarEdge worth $42.6M.

  • Invenomic Capital Management's largest Q4 2023 buy was SolarEdge: 455,600 shares worth $42.6M.
  • Invenomic Capital Management added most to IPG Photonics in Q4 2023, an estimated $11.6M increase.
  • Invenomic Capital Management's biggest Q4 2023 reduction was Corpay, cutting an estimated $40.2M.
  • Invenomic Capital Management fully exited State Street SPDR S&P 500 ETF Trust in Q4 2023, selling an estimated $245M.
  • Invenomic Capital Management's ten largest holdings make up 26% of its $2.19B portfolio in Q4 2023.
  • Invenomic Capital Management opened 59 new positions and closed 32 in Q4 2023.
  • Invenomic Capital Management's portfolio value fell 7.9% quarter-over-quarter to $2.19B.

Based on Invenomic Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.